explore -WSS

explore

author：focus 2025-10-02 00:52:49 - browse：897

ChatGPT chat bot screen seen on smartphone and laptop screens — Adobe

From medical note-taking to analyzing X-rays and mammograms, new artificial intelligence tools are swiftly gaining traction in the world of science and medicine.

STAT is reporting on the use of generative AI — content-creating technology that includes models like ChatGPT and its rivals — in health care and scientific research. We want to hear your questions about how the technology works, its potential in science and medicine, and the risks that it carries. We will answer select questions in a future STAT story, and use these questions more broadly to guide our reporting.

Generative AI in medicine

STAT is reporting on generative AI technologies like ChatGPT in health care and scientific research. What questions do you have about the technology and or its use?Please include your name and email address below. Neither will be published or made public.

NameFirstLast

EmailPrivacy Policy

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： JPM 2024: Verve Therapeutics looks to mainstream genome editing

focus

WSS

The stability of $0 premiums in Medicare Advantage

How I ended up pumping milk in a bathroom stall at JPM 2024

Generative AI mines health records to identify patients’ social needs

RSV injection headlines need to be accurate for good uptake

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Flu, Covid vaccination rates decline, new survey data show

Wikipedia

explore

Generative AI in medicine

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

WHO recommends second malaria vaccine

Activists slam private health insurers over coverage restrictions

Health and fitness trackers are measuring the wrong things

Anesthesiologist group: stop taking Ozempic before surgery

CDC picks Alphabet's Verily for wasterwater surveillance contract

BioMarin wins approval for gene therapy to treat hemophilia A

New Medicare drug pricing powers could soon be upended in court

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD podcast: live from JPM 2024

focus

JPM 2024: Verve Therapeutics looks to mainstream genome editing

6 solutions to address cancer drug shortages and others

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

New England Journal of Medicine addresses racist history, slavery

Doulas covered by Medicaid under New York's new plan

Wikipedia

focus

focus

knowledge